Pure Global

Study for the Management of Chronic and Functional Constipation Through the Intake of Probiotics and Prebiotics - Trial NCT06381193

Access comprehensive clinical trial information for NCT06381193 through Pure Global AI's free database. This phase not specified trial is sponsored by Centros de Investigación de Nutrición y Salud and is currently Completed. The study focuses on Functional Constipation. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06381193
Completed
dietary supplement
Trial Details
ClinicalTrials.govNCT06381193
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study for the Management of Chronic and Functional Constipation Through the Intake of Probiotics and Prebiotics

Study Focus

Functional Constipation

Probiotic

Interventional

dietary supplement

Sponsor & Location

Centros de Investigación de Nutrición y Salud

Madrid, Spain

Timeline & Enrollment

N/A

Mar 03, 2023

Jul 10, 2023

80 participants

Primary Outcome

1. To evaluate the effect of the dietary supplements on the bowel frequency movements in patients with chronic functional constipation.

Summary

The goal of this clinical trial is to learn if supplementation with prebiotics and/or
 probiotics can lead to an improvement in symptoms of patients with functional constipation.
 The main objectives are:
 
 - To evaluate the effect of the dietary supplements on the bowel frequency movements in
 patients with chronic functional constipation, after 8 weeks.
 
 - To evaluate the stool consistency after 8 weeks (Bristol scale).
 
 - To evaluate the quality of life scale score for patients with Constipation (CVE20 and
 GSRS scales), after 8 weeks.
 
 Participants are randomized into the following groups:
 
 - Group A: 20 assigned to probiotic + placebo
 
 - Group B: 20 assigned to prebiotic + placebo
 
 - Group C: 20 assigned to probiotic + prebiotic
 
 - Group D: 20 assigned to the placebo + placebo
 
 Participants took 4 units of product per day (2 of each assigned product) for 2 months.

ICD-10 Classifications

Constipation
Other functional intestinal disorders
Functional intestinal disorder, unspecified
Other specified functional intestinal disorders
Other laxatives

Data Source

ClinicalTrials.gov

NCT06381193

Non-Device Trial